Men's Health in Your 50s

TRT, GLP-1s, ED treatment, and the proactive playbook.

Your 50s are the treatment decade. The conditions that were building in your 30s and crossing thresholds in your 40s are now fully manifested. ED prevalence reaches 33.9%. Testosterone levels have declined 20–40% from peak. Metabolic syndrome affects a significant proportion of men. Prostate screening becomes standard of care. Multi-condition management isn't optional — it's the reality for most men in this decade.

The good news: treatment options have never been better. TRT is now proven safe cardiovascularly (TRAVERSE trial, 2023). GLP-1 medications produce unprecedented weight loss results. ED medications are cheap, effective, and available through telehealth. The men who thrive in their 50s aren't the ones who avoided health issues — they're the ones who treated them proactively.

Your 50s Health Landscape

TRT Consideration Peaks

By age 55, a substantial percentage of men have clinically low testosterone, and the symptoms — fatigue, muscle wasting, bone density loss, sexual dysfunction, depressive mood, cognitive decline — are no longer subtle. For men who have tried weight loss and lifestyle optimization without adequate hormonal improvement, TRT is a legitimate and evidence-based intervention.

The TRAVERSE trial settled the cardiovascular safety question: testosterone replacement in appropriately selected men with cardiovascular risk factors does not increase major adverse cardiovascular events. This removed the single biggest barrier to TRT in older men.

Key considerations in your 50s: fertility is typically no longer a concern (removing the biggest TRT trade-off), but hematocrit monitoring becomes more critical (stroke risk increases with age and elevated red blood cell counts), and PSA monitoring is essential. TrueTRT.co for comprehensive TRT information. PeterMD and MangoRx for TRT programs with monitoring.

ED Requires Active Management

With one in three men experiencing ED by this decade, active treatment is the norm, not the exception. Vascular causes dominate: years of metabolic dysfunction, hypertension, and endothelial damage have compromised the blood flow mechanics that erections depend on. PDE5 inhibitors (sildenafil, tadalafil) remain the first-line treatment and are effective for most men, though higher doses may be needed compared to younger patients.

Daily low-dose tadalafil (2.5–5 mg) is increasingly popular for men in their 50s — it provides both on-demand erectile support and continuous cardiovascular benefits through nitric oxide pathway enhancement. EDPillGuide.com for options. BraveRX for ED prescriptions.

Weight Management Becomes Medical

If you haven't addressed weight gain by your 50s, it's now a medical priority rather than a cosmetic one. Type 2 diabetes risk is elevated, cardiovascular risk is compounding, and the metabolic-hormonal cascade is fully entrenched. GLP-1 medications are the most powerful tool available — and in this decade, they're treating metabolic disease, not just helping you fit into jeans.

Synergy Rx for GLP-1 programs. GLP-1PriceList.com for pricing. HealthyWeightMeds.com for broader weight loss options.

Prostate Screening Begins

The USPSTF recommends shared decision-making about PSA screening for men aged 55–69. If you're on TRT, PSA monitoring is essential regardless of age. Prostate cancer risk increases with age, and early detection through PSA trends (not just single values) significantly improves outcomes.

The 50s Playbook

Full bloodwork every 6 months if on treatment, annually otherwise. Total T, free T, estradiol, hematocrit, PSA, metabolic panel, lipids, thyroid. On TRT, hematocrit above 52% requires intervention.

Embrace multi-condition management. You're likely treating 2–4 conditions simultaneously. A platform that coordinates care beats a collection of specialists. Best platforms comparison.

Prioritize cardiovascular health above all. Heart disease is the leading killer. Everything else — TRT, ED treatment, weight loss — should be coordinated with cardiovascular risk management. This is where the treatment sequencing guide becomes critically important.